In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

Close

logo

English
  • Svenska
  • About us
    About us
      • This is Calliditas
      • Vision and Strategy
      • Board of Directors
      • Management Team
      • Corporate Responsibility
      • Our History
  • Disease overview
    Disease overview
      • IgA nephropathy
      • Nefecon
      • Orphan drugs
      • Scientific Advisory Board
  • Governance
    Governance
      • Corporate Governance Reports
      • Corporate Structure
      • General Meeting
        • General meetings
      • Nomination Committee
        • Nomination committees
      • Board and Committees
        • Board of Directors
        • Board fees
        • Work of the Board of Directors
        • Committees
      • Management
        • Management team
      • Remuneration
      • Internal control and risk management
      • Auditor
      • Articles of Association
  • Investors
    Investors
      • Share issue 2019
      • Capital Markets Day 2019
      • The share
        • Trading information
        • Ownership structure
        • Share capital development
        • Dividend policy
        • Analyst coverage
      • Financial Reports and Presentations
      • Prospectus
      • Press releases
      • Calendar
      • Subscribe
      • Contacts
  • Media
    Media
      • Press releases
      • Calliditas in Media
      • Subscribe
      • Contacts
  • Contacts
    Contacts
      • Offices
      • Partnering
      • Investors
      • Media
      • Career
  • Svenska

Press releases

Read the latest press releases from Calliditas Therapeutics by clicking on a title below.

For press enquiries please contact us.

Non-regulatory press releases
  • Regulatory press releases
  • All press releases
2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2012
  • 2010
  • 2009
  • 2008
  • All years
Nov 4, 2019

Calliditas Therapeutics Capital Markets Day today November 4

Oct 1, 2019

Save the date: Calliditas to host Capital Markets Day in Stockholm on November 4, 2019

Aug 12, 2019

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q2 report

Jun 4, 2019

Calliditas Therapeutics to Present at Redeye Growth Day

May 6, 2019

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q1 report

Apr 5, 2019

Elmar Schnee and Diane Parks proposed as new board members of Calliditas Therapeutics

Apr 3, 2019

Calliditas Therapeutics to Present at the Needham Healthcare Conference

Mar 4, 2019

Calliditas Therapeutics to Present at March Investor Conferences

Feb 1, 2019

Calliditas Therapeutics to host conference call to provide Business Update and 2018 full-year report

Jan 14, 2019

Calliditas Therapeutics appoints Frank Bringstrup as VP Regulatory Affairs

Jan 8, 2019

Calliditas Therapeutics appoints Andrew Udell to VP Commercial, North America

  • Media
    • Press releases
    • Calliditas in Media
    • Subscribe
    • Contacts

Calliditas Therapeutics AB
Kungsbron 1, C8
SE-111 22 Stockholm
Sweden

Company number: 556659-9766

  • Privacy policy
  • About cookies

© Calliditas Therapeutics AB 2019